MINESSE

This brand name is authorized in Austria, Brazil, Spain, France, Ireland, Israel, Tunisia, South Africa

Active ingredients

The drug MINESSE contains a combination of these active pharmaceutical ingredients (APIs):

1 17 alpha-Ethinylestradiol UNII 423D2T571U - ETHINYL ESTRADIOL

Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy. Read about 17 alpha-Ethinylestradiol

2 Gestodene UNII 1664P6E6MI - GESTODENE

Read about Gestodene

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MINESSE Film-coated tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03AA10	Gestodene and ethinylestradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AA Progestogens and estrogens, fixed combinations
Discover more medicines within G03AA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522701802114319
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 3191087-3191186, 63239
Country: FR	Base de données publique des médicaments	Identifier(s): 63615576
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4508, 4509
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5803111
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/18.8/0341